Journal Logo

May 1996 - Volume 24 - Issue 5
pp: 727-902

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shockA multicenter, randomized, placebo-controlled, dose-ranging study

Reinhart, Konrad; Wiegand-Lohnert, Carola; Grimminger, Friedrich; More

Critical Care Medicine. 24(5):733-742, May 1996.

High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan

Zwaveling, Jan H.; Maring, Jan K.; Clarke, Fiona L. FRCA; More

Critical Care Medicine. 24(5):765-770, May 1996.